Physician

Anton P Porsteinsson, MD

According to 2025 Medicare claims, Anton Porsteinsson, MD (NPI: 1740225028) practices general psychiatry in the Rochester, NY market, with the plurality of this provider's patient population coming from Monroe, NY. This provider's primary affiliated billing organization is UNIVERSITY OF ROCHESTER (NPI: 1821152588; TIN: 160743209) and primary practice location at 14620-4200.

Porsteinsson's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 17 traditional Medicare patients, billed 21 HCPCS/CPT codes, and received $1,958 in Medicare payments. The top billing code was 99215 (Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more). Part D data shows 903 prescription claims across 182 beneficiaries totaling $42,495 in drug costs, led by Rivastigmine (Rivastigmine). Open Payments data shows 42 records totaling $285,766. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has fallen sharply in recent years, from $6,567 to $1,958. Similarly, Part D prescription costs started with an early spike, then settled into a lower baseline, moving from $288,538 to $42,495. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$3.9K$7.8K2015 Medicare payment: $6,567 (USD; Tot_Mdcr_Pymt_Amt)2016 Medicare payment: $7,752 (USD; Tot_Mdcr_Pymt_Amt)2017 Medicare payment: $7,847 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $5,959 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $4,845 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $2,339 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $3,937 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $3,402 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $2,544 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $1,958 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
20156190$6,567
201671108$7,752
201782109$7,847
20185581$5,959
20195270$4,845
20203036$2,339
20212638$3,937
20222537$3,402
20232030$2,544
20241721$1,958

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$144K$289K2015 Drug cost: $288,538 (USD; Tot_Drug_Cst)2016 Drug cost: $252,401 (USD; Tot_Drug_Cst)2017 Drug cost: $254,939 (USD; Tot_Drug_Cst)2018 Drug cost: $169,767 (USD; Tot_Drug_Cst)2019 Drug cost: $149,053 (USD; Tot_Drug_Cst)2020 Drug cost: $115,126 (USD; Tot_Drug_Cst)2021 Drug cost: $81,547 (USD; Tot_Drug_Cst)2022 Drug cost: $63,173 (USD; Tot_Drug_Cst)2023 Drug cost: $65,523 (USD; Tot_Drug_Cst)2024 Drug cost: $42,495 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
20152171,782$288,538
20162301,884$252,401
20172311,868$254,939
20182011,822$169,767
20191961,613$149,053
20201641,175$115,126
2021134934$81,547
2022106738$63,173
2023138868$65,523
2024182903$42,495

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
99215Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more1519$95

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
RivastigmineRivastigmine653,630$11,242
Memantine HclMemantine Hcl20911,687$6,528
Memantine Hcl ErMemantine Hcl633,166$5,842
Galantamine ErGalantamine Hbr452,490$5,107
Donepezil HclDonepezil Hcl1679,760$1,342

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.30$50,265Novo Nordisk AS
Research PaymentsReported research-related payment or transfer-of-value amount.12$235,502Eli Lilly and Company
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Anton P. Porsteinsson, MD?

Tedicare shows public-source Medicare data for Anton P. Porsteinsson, MD (NPI 1740225028), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Anton P. Porsteinsson, MD have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Anton P. Porsteinsson, MD?

Anton P. Porsteinsson, MD is linked to UNIVERSITY OF ROCHESTER (billing NPI 1821152588) in the available physician profile data.

Does Anton P. Porsteinsson, MD have Open Payments data?

Anton P. Porsteinsson, MD has 42 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.